Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Validation of early drain removal after pancreatoduodenectomy based on modified fistula risk score stratification: a population-based assessment.

Xourafas D, Ejaz A, Tsung A, Dillhoff M, Pawlik TM, Cloyd JM.

HPB (Oxford). 2019 Mar 18. pii: S1365-182X(19)30076-0. doi: 10.1016/j.hpb.2019.02.002. [Epub ahead of print]

PMID:
30898434
2.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
3.

A national assessment of the utilization, quality and cost of laparoscopic liver resection.

Gani F, Ejaz A, Dillhoff M, He J, Weiss M, Wolfgang CL, Cloyd J, Tsung A, Johnston FM, Pawlik TM.

HPB (Oxford). 2019 Mar 5. pii: S1365-182X(19)30081-4. doi: 10.1016/j.hpb.2019.02.005. [Epub ahead of print]

PMID:
30850188
4.

Association Between Travel Distance, Hospital Volume, and Outcomes Following Resection of Cholangiocarcinoma.

Beal EW, Mehta R, Hyer JM, Paredes A, Merath K, Dillhoff ME, Cloyd J, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Feb 27. doi: 10.1007/s11605-019-04162-8. [Epub ahead of print]

PMID:
30815777
5.

Use of perioperative epidural analgesia among Medicare patients undergoing hepatic and pancreatic surgery.

Merath K, Hyer JM, Mehta R, Bagante F, Paredes A, Wu L, Sahara K, Dillhoff M, Cloyd J, Ejaz A, Tsung A, Pawlik TM.

HPB (Oxford). 2019 Feb 2. pii: S1365-182X(19)30011-5. doi: 10.1016/j.hpb.2018.12.008. [Epub ahead of print]

PMID:
30718186
6.

Impact of concomitant ablation on the perioperative outcomes of patients with colorectal liver metastases undergoing hepatectomy: a propensity score matched nationwide analysis.

Xourafas D, Pawlik TM, Ejaz A, Dillhoff M, Abdel-Misih S, Tsung A, Cloyd JM.

HPB (Oxford). 2019 Feb 1. pii: S1365-182X(19)30013-9. doi: 10.1016/j.hpb.2018.12.010. [Epub ahead of print]

PMID:
30718184
7.

Evidence Versus Practice in Early Drain Removal After Pancreatectomy.

Villafane-Ferriol N, Baugh KA, McElhany AL, Van Buren G 2nd, Fang A, Tashakori EK, Reyes JEM, Cao HST, Silberfein EJ, Massarweh N, Hsu C, Barakat O, Schmidt C, Zyromski NJ, Dillhoff M, Villarreal JA, Fisher WE.

J Surg Res. 2019 Apr;236:332-339. doi: 10.1016/j.jss.2018.11.048. Epub 2019 Jan 4.

PMID:
30694774
8.

Gastric carcinoids: Does type of surgery or tumor affect survival?

Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Smith PM, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG.

Am J Surg. 2018 Dec 28. pii: S0002-9610(18)31451-X. doi: 10.1016/j.amjsurg.2018.12.057. [Epub ahead of print]

PMID:
30686481
9.

Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors.

Fisher AV, Lopez-Aguiar AG, Rendell VR, Pokrzywa C, Rocha FG, Kanji ZS, Poultsides GA, Makris EA, Dillhoff ME, Beal EW, Fields RC, Panni RZ, Idrees K, Smith PM, Cho CS, Beems MV, Maithel SK, Winslow ER, Abbott DE, Weber SM.

J Gastrointest Surg. 2019 Apr;23(4):651-658. doi: 10.1007/s11605-018-04080-1. Epub 2019 Jan 18.

PMID:
30659439
10.

Population-Based Assessment of Selective Drain Placement During Pancreatoduodenectomy Using the Modified Fistula Risk Score.

Xourafas D, Ejaz A, Tsung A, Dillhoff M, Pawlik TM, Cloyd JM.

J Am Coll Surg. 2019 Apr;228(4):583-591. doi: 10.1016/j.jamcollsurg.2018.12.007. Epub 2018 Dec 23.

PMID:
30586644
11.

Routine intensive care unit admission among patients undergoing major pancreatic surgery for cancer: No effect on failure to rescue.

Cerullo M, Gani F, Chen SY, Canner JK, Dillhoff M, Cloyd J, Pawlik TM.

Surgery. 2019 Apr;165(4):741-746. doi: 10.1016/j.surg.2018.11.005. Epub 2018 Dec 11.

PMID:
30551866
12.

Predictors of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Paredes AZ, Abdel-Misih S, Schmidt C, Dillhoff ME, Pawlik TM, Cloyd JM.

J Surg Res. 2019 Feb;234:103-109. doi: 10.1016/j.jss.2018.09.022. Epub 2018 Oct 5.

PMID:
30527460
13.

Perioperative use of blood products is associated with risk of morbidity and mortality after surgery.

Beal EW, Bagante F, Paredes A, Akgul O, Merath K, Cua S, Dillhoff ME, Schmidt CR, Abel E, Scrape S, Ejaz A, Pawlik TM.

Am J Surg. 2018 Nov 27. pii: S0002-9610(18)31376-X. doi: 10.1016/j.amjsurg.2018.11.015. [Epub ahead of print]

PMID:
30509453
14.

Textbook Outcomes Among Medicare Patients Undergoing Hepatopancreatic Surgery.

Merath K, Chen Q, Bagante F, Beal E, Akgul O, Dillhoff M, Cloyd JM, Pawlik TM.

Ann Surg. 2018 Nov 29. doi: 10.1097/SLA.0000000000003105. [Epub ahead of print]

PMID:
30499800
15.

Hot spotting surgical patients undergoing hepatopancreatic procedures.

Merath K, Chen Q, Johnson M, Mehta R, Beal EW, Dillhoff M, Cloyd J, Pawlik TM.

HPB (Oxford). 2018 Nov 26. pii: S1365-182X(18)34508-8. doi: 10.1016/j.hpb.2018.10.011. [Epub ahead of print]

PMID:
30497897
16.

Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.

Ramsey ML, Talbert E, Ahn D, Bekaii-Saab T, Badi N, Bloomston PM, Conwell DL, Cruz-Monserrate Z, Dillhoff M, Farren MR, Hinton A, Krishna SG, Lesinski GB, Mace T, Manilchuk A, Noonan A, Pawlik TM, Rajasekera PV, Schmidt C, Guttridge D, Hart PA.

Pancreatology. 2019 Jan;19(1):80-87. doi: 10.1016/j.pan.2018.11.002. Epub 2018 Nov 10.

PMID:
30497874
17.

The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group.

Zaidi MY, Lopez-Aguiar AG, Poultsides GA, Dillhoff M, Rocha FG, Idrees K, Nathan H, Winslow ER, Fields RC, Cardona K, Maithel SK; and other members of the US Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Jan;119(1):5-11. doi: 10.1002/jso.25306. Epub 2018 Nov 27.

PMID:
30481383
18.

Postoperative Pancreatic Fistula Following Pancreaticoduodenectomy-Stratification of Patient Risk.

Akgul O, Merath K, Mehta R, Hyer JM, Chakedis J, Wiemann B, Johnson M, Paredes A, Dillhoff M, Cloyd J, Pawlik TM.

J Gastrointest Surg. 2018 Nov 26. doi: 10.1007/s11605-018-4045-x. [Epub ahead of print]

PMID:
30478529
19.

Procedure-Specific Volume and Nurse-to-Patient Ratio: Implications for Failure to Rescue Patients Following Liver Surgery.

Chen Q, Olsen G, Bagante F, Merath K, Idrees JJ, Akgul O, Cloyd J, Dillhoff M, White S, Pawlik TM.

World J Surg. 2019 Mar;43(3):910-919. doi: 10.1007/s00268-018-4859-4.

PMID:
30465087
20.

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases.

McDermott SM, Saunders ND, Schneider EB, Strosberg D, Onesti J, Dillhoff M, Schmidt CR, Shirley LA.

J Surg Res. 2018 Dec;232:369-375. doi: 10.1016/j.jss.2018.06.058. Epub 2018 Jul 18.

PMID:
30463743
21.

Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small Bowel Neuroendocrine Tumors.

Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, Rocha F, Crown A, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett JR, Fields RC, Davidson J, Cardona K, Maithel SK.

JAMA Surg. 2018 Oct 31. doi: 10.1001/jamasurg.2018.3865. [Epub ahead of print]

PMID:
30383112
22.

Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.

Kimbrough CW, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola-Smith P, Cho CS, Beems M, Maithel SK, Cloyd JM.

Surgery. 2019 Mar;165(3):657-663. doi: 10.1016/j.surg.2018.09.008. Epub 2018 Oct 28.

PMID:
30377003
23.

Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.

Chakedis J, Beal EW, Sun S, Galo J, Chafitz A, Davidson G, Reardon J, Dillhoff M, Pawlik TM, Abdel-Misih S, Bloomston M, Schmidt CR.

J Surg Oncol. 2018 Dec;118(7):1065-1073. doi: 10.1002/jso.25249.

PMID:
30376157
24.

Role of associating liver partition and portal vein ligation in staged hepatectomy (ALPPS)-strategy for colorectal liver metastases.

Abbasi A, Rahnemai-Azar AA, Merath K, Weber SM, Abbott DE, Dillhoff M, Cloyd J, Pawlik TM.

Transl Gastroenterol Hepatol. 2018 Sep 17;3:66. doi: 10.21037/tgh.2018.09.03. eCollection 2018. Review.

25.

Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.

Chakedis J, Beal EW, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha FG, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Marincola-Smith P, Cho C, Beems M, Pawlik TM, Maithel SK, Schmidt CR, Dillhoff M.

J Gastrointest Surg. 2019 Jan;23(1):122-134. doi: 10.1007/s11605-018-3986-4. Epub 2018 Oct 17.

PMID:
30334178
26.

Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.

Zhang XF, Wu Z, Cloyd J, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Schmidt CR, Dillhoff M, Maithel SK, Pawlik TM.

Surgery. 2019 Mar;165(3):548-556. doi: 10.1016/j.surg.2018.08.015. Epub 2018 Sep 29.

PMID:
30278986
27.

Variation in the cost-of-rescue among medicare patients with complications following hepatopancreatic surgery.

Merath K, Chen Q, Bagante F, Sun S, Akgul O, Idrees JJ, Dillhoff M, Schmidt C, Cloyd J, Pawlik TM.

HPB (Oxford). 2019 Mar;21(3):310-318. doi: 10.1016/j.hpb.2018.08.005. Epub 2018 Sep 25.

PMID:
30266495
28.

Population level outcomes and costs of single stage colon and liver resection versus conventional two-stage approach for the resection of metastatic colorectal cancer.

Idrees JJ, Bagante F, Gani F, Rosinski BF, Chen Q, Merath K, Dillhoff M, Cloyd J, Pawlik TM.

HPB (Oxford). 2018 Sep 25. pii: S1365-182X(18)33937-6. doi: 10.1016/j.hpb.2018.08.007. [Epub ahead of print]

PMID:
30266492
29.

Patterns of readmission among the elderly after hepatopancreatobiliary surgery.

Paredes AZ, Beal EW, Bagante F, Dillhoff ME, Cloyd JM, Pawlik TM.

Am J Surg. 2019 Mar;217(3):413-416. doi: 10.1016/j.amjsurg.2018.09.011. Epub 2018 Sep 21.

PMID:
30262121
30.

Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors.

Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA.

Ann Surg Oncol. 2018 Nov;25(12):3613-3620. doi: 10.1245/s10434-018-6741-x. Epub 2018 Sep 4.

PMID:
30182331
31.

Prognosis and Adherence with the National Comprehensive Cancer Network Guidelines of Patients with Biliary Tract Cancers: an Analysis of the National Cancer Database.

Bagante F, Gani F, Beal EW, Merath K, Chen Q, Dillhoff M, Cloyd J, Pawlik TM.

J Gastrointest Surg. 2019 Mar;23(3):518-528. doi: 10.1007/s11605-018-3912-9. Epub 2018 Aug 15.

PMID:
30112703
32.

Time to Readmission and Mortality Among Patients Undergoing Liver and Pancreatic Surgery.

Chen Q, Bagante F, Olsen G, Merath K, Idrees JJ, Beal EW, Akgul O, Cloyd J, Dillhoff M, Schmidt C, White S, Pawlik TM.

World J Surg. 2019 Jan;43(1):242-251. doi: 10.1007/s00268-018-4766-8.

PMID:
30109390
33.

The relationship of hospital market concentration, costs, and quality for major surgical procedures.

Cerullo M, Chen SY, Gani F, Idrees J, Dillhoff M, Schmidt C, Canner JK, Cloyd J, Pawlik TM.

Am J Surg. 2018 Dec;216(6):1037-1045. doi: 10.1016/j.amjsurg.2018.07.042. Epub 2018 Jul 25.

PMID:
30060911
34.

A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population.

Chen Q, Merath K, Bagante F, Akgul O, Dillhoff M, Cloyd J, Pawlik TM.

J Gastrointest Surg. 2018 Dec;22(12):2088-2096. doi: 10.1007/s11605-018-3883-x. Epub 2018 Jul 23.

PMID:
30039449
35.

Index versus Non-index Readmission After Hepato-Pancreato-Biliary Surgery: Where Do Patients Go to Be Readmitted?

Beal EW, Bagante F, Paredes A, Chen Q, Akgul O, Merath K, Dillhoff ME, Cloyd JM, Pawlik TM.

J Gastrointest Surg. 2019 Apr;23(4):702-711. doi: 10.1007/s11605-018-3882-y. Epub 2018 Jul 23.

PMID:
30039444
36.

Practices and Perceptions Among Surgical Oncologists in the Perioperative Care of Obese Cancer Patients.

Hughes TM, Palmer EN, Capers Q, Abdel-Misih S, Harzmann A, Beal E, Woelfel I, Noria S, Agnese D, Dillhoff M, Grignol V, Howard JH, Shirley LA, Terando A, Schmidt C, Cloyd J, Pawlik T.

Ann Surg Oncol. 2018 Sep;25(9):2513-2519. doi: 10.1245/s10434-018-6564-9. Epub 2018 Jul 9.

PMID:
29987611
37.

Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery.

Merath K, Chen Q, Bagante F, Akgul O, Idrees JJ, Dillhoff M, Cloyd JM, Pawlik TM.

J Gastrointest Surg. 2018 Oct;22(10):1715-1723. doi: 10.1007/s11605-018-3829-3. Epub 2018 Jun 18.

PMID:
29916105
38.

Challenges of surgical management of intrahepatic cholangiocarcinoma.

Squires MH, Cloyd JM, Dillhoff M, Schmidt C, Pawlik TM.

Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):671-681. doi: 10.1080/17474124.2018.1489229. Epub 2018 Jun 27. Review.

PMID:
29911912
39.

The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample.

Idrees JJ, Kimbrough CW, Rosinski BF, Schmidt C, Dillhoff ME, Beal EW, Bagante F, Merath K, Chen Q, Cloyd JM, Ellison EC, Pawlik TM.

J Gastrointest Surg. 2018 Oct;22(10):1688-1696. doi: 10.1007/s11605-018-3826-6. Epub 2018 May 31.

PMID:
29855870
40.

Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.

Chakedis J, Spolverato G, Beal EW, Woelfel I, Bagante F, Merath K, Sun SH, Chafitz A, Galo J, Dillhoff M, Cloyd J, Pawlik TM.

J Gastrointest Surg. 2018 Oct;22(10):1697-1708. doi: 10.1007/s11605-018-3802-1. Epub 2018 May 31.

PMID:
29855867
41.

Inflammatory myofibroblastic tumour: an unusual presentation including small bowel obstruction and palpable abdominal mass.

Cerier E, Beal EW, Dillhoff ME.

BMJ Case Rep. 2018 May 15;2018. pii: bcr-2018-224549. doi: 10.1136/bcr-2018-224549.

PMID:
29764851
42.

The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis.

Merath K, Bagante F, Chen Q, Beal EW, Akgul O, Idrees J, Dillhoff M, Cloyd J, Schmidt C, Pawlik TM.

J Gastrointest Surg. 2018 Sep;22(9):1538-1548. doi: 10.1007/s11605-018-3783-0. Epub 2018 May 7.

PMID:
29736663
43.

Identifying Clinical Factors Which Predict for Early Failure Patterns Following Resection for Pancreatic Adenocarcinoma in Patients Who Received Adjuvant Chemotherapy Without Chemoradiation.

Walston S, Salloum J, Grieco C, Wuthrick E, Diaz DA, Barney C, Manilchuk A, Schmidt C, Dillhoff M, Pawlik TM, Williams TM.

Am J Clin Oncol. 2018 Dec;41(12):1185-1192. doi: 10.1097/COC.0000000000000452.

PMID:
29727311
44.

Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC.

Cloyd JM, Abdel-Misih S, Hays J, Dillhoff ME, Pawlik TM, Schmidt C.

J Gastrointest Surg. 2018 Sep;22(9):1576-1584. doi: 10.1007/s11605-018-3784-z. Epub 2018 Apr 30.

PMID:
29713875
45.

Perioperative complications and the cost of rescue or failure to rescue in hepato-pancreato-biliary surgery.

Chen Q, Beal EW, Kimbrough CW, Bagante F, Merath K, Dillhoff M, Schmidt C, White S, Cloyd J, Pawlik TM.

HPB (Oxford). 2018 Sep;20(9):854-864. doi: 10.1016/j.hpb.2018.03.010. Epub 2018 Apr 22.

PMID:
29691125
46.

Epidermoid cyst within an intrapancreatic accessory spleen.

Paredes A, Beal EW, Dillhoff ME.

BMJ Case Rep. 2018 Apr 5;2018. pii: bcr-2017-223600. doi: 10.1136/bcr-2017-223600.

PMID:
29622708
47.

Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency.

Rahnemai-Azar AA, Cloyd JM, Weber SM, Dillhoff M, Schmidt C, Winslow ER, Pawlik TM.

J Clin Transl Hepatol. 2018 Mar 28;6(1):97-104. doi: 10.14218/JCTH.2017.00060. Epub 2017 Nov 30. Review.

48.

Impact of Post-Discharge Disposition on Risk and Causes of Readmission Following Liver and Pancreas Surgery.

Chen Q, Merath K, Olsen G, Bagante F, Idrees JJ, Akgul O, Cloyd J, Schmidt C, Dillhoff M, Beal EW, White S, Pawlik TM.

J Gastrointest Surg. 2018 Jul;22(7):1221-1229. doi: 10.1007/s11605-018-3740-y. Epub 2018 Mar 22.

PMID:
29569005
49.

Hospital Teaching Status and Medicare Expenditures for Hepato-Pancreato-Biliary Surgery.

Chen Q, Bagante F, Merath K, Idrees J, Beal EW, Cloyd J, Dillhoff M, Schmidt C, Diaz A, White S, Pawlik TM.

World J Surg. 2018 Sep;42(9):2969-2979. doi: 10.1007/s00268-018-4566-1.

PMID:
29564518
50.

Sequential drain amylase to guide drain removal following pancreatectomy.

Villafane-Ferriol N, Van Buren G 2nd, Mendez-Reyes JE, McElhany AL, Massarweh NN, Silberfein EJ, Hsu C, Tran Cao HS, Schmidt C, Zyromski NJ, Dillhoff ME, Roch A, Oliva E, Smith AC, Zhang Q, Fisher WE.

HPB (Oxford). 2018 Jun;20(6):514-520. doi: 10.1016/j.hpb.2017.11.008. Epub 2018 Feb 23.

PMID:
29478737

Supplemental Content

Loading ...
Support Center